On March 5, 2026, Belén Garijo, Chair of the Executive Board and CEO of Merck Group of Germany, stated in an interview with Xinhua News Agency that Merck Group has always attached great importance to the Chinese market and plans to further increase its investment in China. Garijo said that as China has become an important source of global innovation, Merck is actively seeking cooperation with Chinese companies to jointly develop new drugs and technologies, which will benefit the world. She emphasized that Merck is full of confidence in China's economic growth prospects and regards China as its preferred partner.
